Study of Anginera in Adults With a Left Ventricular Assist Device (LVAD) as Bridge to Transplant
Status:
Unknown status
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to obtain human heart tissue after treatment with Anginera to
determine its effect on a variety of things that might indicate improvement in heart
function. Patients who will have a left ventricular assist device (LVAD) implanted while they
wait for a donated heart will be treated with Anginera. At the time of heart transplant,
their diseased heart which is removed will be analyzed by microscopic examination to see what
effect Anginera had.